Care Beyond Allergy
![](/sites/default/files/annual-reports/sg-2023-annreport-uk-final-31-text1.jpg)
![](/sites/default/files/annual-reports/sg-2023-annreport-uk-final-31-text2.jpg)
•
2021
Maturity assessment
•
2022
Materiality analysis
“Care Beyond Allergy” corporate responsibility programme
20 commitments
•
2023
Definition of strategic key performance indicators (KPI)
Updating of corporate responsibility governance model
•
2024
Preparation for CSRD requirements
Double materiality assessment
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-58.png)
SOCIETY
“Patient needs drive our innovation to fight against all kinds of allergies”
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-59.png)
ENVIRONMENT
“We are committed to advancing climate action and preserving nature to boost the prevention and treatment of allergies”
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-59-2.png)
SOCIAL
“Investing in our people and empowering them to unleash their full potential”
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-59-3.png)
GOVERNANCE
“Building trust with our stakeholders every day”
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-58-2.png)
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-59-4.png)
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-59-5.png)
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-59-6.png)
Care Beyond Allergy, moving forward with determination
2023 marks an important milestone for our Care Beyond Allergy programme with the definition of 12 KPIs which provide a quantifiable, objective and transparent basis for measuring progress toward our 2030 corporate responsibility ambition, while aligning with the Group’s business goals.
In 2024, Stallergenes Greer will establish the baseline for all the Group’s KPIs to ensure that measurement processes are robust and correctly reflect our commitment to sustainability. To further solidify our environmental stewardship, we are working with external experts to define reduction trends such as those pertaining to greenhouse gas (GhG) emissions.
The integration of corporate responsibility initiatives in our Group’s objectives illustrates our commitment to sustainable business practices. Through regular updates at Stallergenes Greer’s Strategic Project Committee and thorough discussions at the Corporate Responsibility Committee, we ensure that corporate responsibility is a fundamental component of our organisational strategy.
Stallergenes Greer is proactively preparing for the future European Corporate Sustainability Reporting Directive (CSRD) requirements applicable in 2026. By staying ahead of regulatory changes, the Group is assuring its readiness to meet evolving standards and strengthening its determination to embrace comprehensive sustainability practices.
Key commitments
2030 ambition
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-60.png)
SOCIETY
Accelerate research to offer a comprehensive portfolio of innovative and personalised solutions against allergies
Contribute to gathering scientific and medical knowledge on allergies and the socioeconomic impact of allergen immunotherapy
Ensure patient security and treatment supply
Join efforts with patients and practitioners to enhance the quality of life of allergy sufferers and improve the patient journey
Extend access to and use of Stallergenes Greer allergen immunotherapy products
Increase the production capacity of our new sublingual specialty production line each year
Empower patients by integrating their voice in our initiatives
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-60-2.png)
ENVIRONMENT
Support our sites in adjusting to environmental challenges
Use natural resources responsibly
Contribute to the objectives of the Paris Agreement
Implement eco-friendly packaging solutions
Increase awareness on environmental challenges
Support research in environmental health and ecology of health, with a specific focus on the impact of air pollution on respiratory diseases
Ensure that volume growth until 2030 will be delivered by reaching efficiencies on water consumption
Reduce our GhG emissions (scope 1, 2, 3) compared to baseline
An eco-friendly pack pilot for sublingual specialty available for implementation in manufacturing by 2025
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-60-3.png)
SOCIAL
Be a safe place to work
Be the right place to work
Invest in training and professional development
Upgrade our talent programme to anticipate tomorrow’s musthave skills
Foster a diverse and inclusive workplace
Maintain the injury frequency rate to less or equal to 3,5%
Increase every other year employee satisfaction as measured by well-being survey
100% of employees will have followed training and e learning annually (excluding mandatory trainings by law) by 2030
Include all employees in people review program
![](/sites/default/files/annual-reports/2023/sg-2023-annreport-uk-final-print2-copie-60-4.png)
GOVERNANCE
Deploy a committed corporate responsibility governance
Integrate sustainability as a shared value across our organization
Integrate environmental criteria in our risk management processes
Implement a responsible procurement policy
Maintain high standards by conducting business with integrity
100% of key third parties considered as critical from a compliance standpoint will be assessed for their integrity in conducting business
Expand each year the coverage of corporate responsibility assessments of our active supplier database